Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene on chromosome 22

BACKGROUND A well-characterized single nucleotide polymorphism (472G/A-Val/Met-SNP8) in the coding sequence of the catechol-O-methyltransferase (COMT) gene leads to a three- to fourfold difference in enzymatic activity and clinical and animal studies suggest a role in anxiety states like panic disorder. METHODS Subjects from 70 panic disorder pedigrees, and 83 "triads", were genotyped at seven single nucleotide polymorphisms (SNPs), polymorphic microsatellites in the first intron of COMT and approximately 339kb upstream of COMT (D22S944) and analyzed for genetic association and linkage. RESULTS Linkage analysis showed elevated LOD scores for 472G/A (SNP 8), silent exon 3 substitution (186C/T-SNP 5), and the marker D22S944 (2.88, 2.62, and 2.93, respectively), using a variety of diagnostic and genetic models. Association tests were not significant for the SNPs, but were highly significant for D22S944 (p =.0001-.0003). One three-marker haplotype formed from the above three polymorphisms was significantly associated with panic disorder (p =.0001), as was the "global" p value for this combination (p =.005). In addition, numerous haplotypes with combinations of D22S944 and COMT SNPs were found to be significantly associated with panic disorder. CONCLUSIONS Our findings provide strong evidence for a susceptibility locus for panic disorder either within the COMT gene or in a nearby region of chromosome 22.

[1]  J. Volavka,et al.  Analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association with aggressive and antisocial behavior , 1997, Psychiatry Research.

[2]  J. Ott.  Analysis of Human Genetic Linkage , 1985 .

[3]  S. Hodge,et al.  Lack of genetic linkage or association between a functional serotonin transporter polymorphism and panic disorder. , 1999, Psychiatric genetics.

[4]  J. Terwilliger.  A powerful likelihood method for the analysis of linkage disequilibrium between trait loci and one or more polymorphic marker loci. , 1995, American journal of human genetics.

[5]  K. Ohara,et al.  No association between anxiety disorders and catechol-O-methyltransferase polymorphism , 1998, Psychiatry Research.

[6]  G. Eisenhofer,et al.  Catecholamine Metabolism: From Molecular Understanding to Clinical Diagnosis and Treatment , 1997 .

[7]  S E Hodge,et al.  Direct power comparisons between simple LOD scores and NPL scores for linkage analysis in complex diseases. , 1999, American journal of human genetics.

[8]  K. Yonkers.  Panic Disorder in Women , 1994 .

[9]  G. Benson,et al.  Tandem repeats finder: a program to analyze DNA sequences. , 1999, Nucleic acids research.

[10]  D. Pfaff,et al.  Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[11]  R. Weinshilboum,et al.  Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. , 1996, Pharmacogenetics.

[12]  Jurg Ott,et al.  Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder , 1999, Biological Psychiatry.

[13]  J. Vincent,et al.  Investigation of cholecystokinin system genes in panic disorder , 1999, Molecular Psychiatry.

[14]  R. Mathew,et al.  Catechol-O-methyltransferase and catecholamines in anxiety and relaxation , 1980, Psychiatry Research.

[15]  Paul M. Sharp,et al.  Codon usage in yeast: cluster analysis clearly differentiates highly and lowly expressed genes , 1986, Nucleic Acids Res..

[16]  D G Clayton,et al.  Fine genetic mapping using haplotype analysis and the missing data problem , 1998, Annals of human genetics.

[17]  R. Noyes,et al.  Candidate gene study of eight GABAA receptor subunits in panic disorder. , 1997, The American journal of psychiatry.

[18]  T. Kiviluoto,et al.  Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters. , 1994, European journal of biochemistry.

[19]  N Risch,et al.  The Future of Genetic Studies of Complex Human Diseases , 1996, Science.

[20]  R. Kessler,et al.  Panic disorder in women: a population-based twin study , 1993, Psychological Medicine.

[21]  Eric Lander Leonid Kruglyak.  Genetic dissection of complex traits , 1996, Nature Genetics.

[22]  S. Hodge,et al.  No association or linkage between polymorphisms in the genes encoding cholecystokinin and the cholecystokinin B receptor and panic disorder , 2001, Molecular Psychiatry.

[23]  P. Kwok,et al.  Fluorescence polarization in homogeneous nucleic acid analysis. , 1999, Genome research.

[24]  N. Risch,et al.  A comparison of linkage disequilibrium measures for fine-scale mapping. , 1995, Genomics.

[25]  Z Dembic,et al.  Human catechol-O-methyltransferase: cloning and expression of the membrane-associated form. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[26]  E. Lander,et al.  Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results , 1995, Nature Genetics.

[27]  Genetic linkage study of panic: clinical methodology and description of pedigrees. , 1999 .

[28]  I. Ulmanen,et al.  Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. , 1995, Biochemistry.

[29]  S E Hodge,et al.  Results of a genome-wide genetic screen for panic disorder. , 1998, American journal of medical genetics.

[30]  A A Schäffer,et al.  Avoiding recomputation in linkage analysis. , 1994, Human heredity.

[31]  W. Ewens,et al.  Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). , 1993, American journal of human genetics.

[32]  J. Ott,et al.  Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A A Schäffer,et al.  Faster sequential genetic linkage computations. , 1993, American journal of human genetics.

[34]  G Kalsi,et al.  Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. , 2001, American journal of human genetics.

[35]  C. Falk,et al.  Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations , 1987, Annals of human genetics.

[36]  Kenneth K Kidd,et al.  Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles , 1999, Biological Psychiatry.

[37]  S. Hodge,et al.  Investigation of dopamine receptor (DRD4) and dopamine transporter (DAT) polymorphisms for genetic linkage or association to panic disorder. , 2000, American journal of medical genetics.

[38]  Jurg Ott,et al.  Handbook of Human Genetic Linkage , 1994 .

[39]  J Lellouch,et al.  The cross-national epidemiology of panic disorder. , 1997, Archives of general psychiatry.

[40]  D. Klein,et al.  Schedule for Affective Disorders and Schizophrenia--Lifetime Version modified for the study of anxiety disorders (SADS-LA): rationale and conceptual development. , 1986, Journal of psychiatric research.

[41]  D. Rao,et al.  Segregation analysis of dopamine‐beta‐hydroxylase (DBH) and catechol‐o‐methyltransferase (COMT): Identification of major locus and polygenic components , 1985, Genetic epidemiology.

[42]  J. Gilbert,et al.  SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease. , 2000, American journal of human genetics.

[43]  S E Hodge,et al.  The power to detect linkage in complex disease by means of simple LOD-score analyses. , 1998, American journal of human genetics.

[44]  J. Terwilliger,et al.  A haplotype-based 'haplotype relative risk' approach to detecting allelic associations. , 1992, Human heredity.

[45]  R Shulman,et al.  Catechol-O-Methyl Transferase Activity in Patients with Depressive Illness and Anxiety States , 1978, British Journal of Psychiatry.

[46]  D. Murphy,et al.  Segregation and linkage studies of plasma dopamine-beta-hydroxylase (DBH), erythrocyte catechol-O-methyltransferase (COMT), and platelet monoamine oxidase (MAO): possible linkage between the ABO locus and a gene controlling DBH activity. , 1982, American journal of human genetics.

[47]  M. Nöthen,et al.  Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. , 1999, Human molecular genetics.

[48]  D. Curtis,et al.  Monte Carlo tests for associations between disease and alleles at highly polymorphic loci , 1995, Annals of human genetics.

[49]  L. Wetterberg,et al.  Erythrocyte catechol‐O‐methyltransferase activity in a Swedish population , 1981, Clinical genetics.

[50]  S E Hodge,et al.  Magnitude of type I error when single-locus linkage analysis is maximized over models: a simulation study. , 1997, American journal of human genetics.

[51]  S. Ho,et al.  Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. , 1999, Molecular pharmacology.